Company: SABR
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001597033-25-000027
Chunk: 70

Company: Sabre Corp
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 70
---
4, 2023 and 2022. The following table summarizes the stock option award activities under our outstanding equity-based compensation plans and agreements for the year ended December 31, 2024:  Weighted-Average  QuantityExercise PriceRemainingContractualTerm (years)AggregateIntrinsic Value (in thousands) (1)Outstanding at December 31, 20231,747,755 $12.20 5.5$— Expired(112,978)14.96 Outstanding at December 31, 20241,634,777 $12.01 4.6$— Vested and exercisable at December 31, 20241,634,777 $12.01 4.6$— ______________________(1)Aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock options awards and the closing price of our common stock of $3.65 and $4.40 on December 31, 2024 and 2023, respectively. If the aggregate intrinsic value is negative, it is assigned a nil value. There were no options exercised during the years ended December 31, 2024 and 2023, and the total intrinsic value of stock options exercised was immaterial for the year ended December 31, 2022. As of December 31, 2024, there was no unrecognized compensation expense associated with stock options.

88

The following table summarizes the activities for our RSUs for the year ended December 31, 2024:QuantityWeighted-AverageGrant Date Fair ValueUnvested at December 31, 202320,585,195 $5.10 Granted18,685,645 3.17 Vested(8,296,949)6.11 Forfeited(3,971,610)3.78 Unvested at December 31, 202427,002,281 $3.65 The total fair value of RSUs vested, as of their respective vesting dates, was $48 million, $51 million, and $68 million during the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, approximately $66 million in unrecognized compensation expense associated with RSUs will be recognized over a weighted average period of 2.7 years.The following table summarizes the activities for our PSUs for the